Rearrest
Rearrest[edit | edit source]
Rearrest refers to the recurrence of cardiac arrest in a patient who has previously been resuscitated. This medical condition is critical and requires immediate intervention to prevent further complications or death. Rearrest can occur due to various underlying causes, including unresolved cardiac issues, electrolyte imbalances, or inadequate initial resuscitation.
Causes[edit | edit source]
The causes of rearrest are often related to the initial factors that led to the first cardiac arrest. Common causes include:
- Cardiac Causes: These include myocardial infarction, arrhythmia, and heart failure.
- Respiratory Causes: Conditions such as pulmonary embolism or severe asthma can lead to rearrest.
- Metabolic Causes: Electrolyte imbalances, such as hyperkalemia or hypocalcemia, can precipitate rearrest.
- Neurological Causes: Severe stroke or seizures may contribute to the recurrence of cardiac arrest.
Management[edit | edit source]
The management of rearrest involves immediate Advanced Cardiac Life Support (ACLS) protocols. Key steps include:
- Immediate CPR: Cardiopulmonary resuscitation should be initiated immediately to maintain circulation.
- Defibrillation: If the rearrest is due to a shockable rhythm, such as ventricular fibrillation, defibrillation should be performed.
- Medication: Administration of medications such as epinephrine or amiodarone may be necessary.
- Addressing Underlying Causes: Identifying and treating the underlying cause of the rearrest is crucial for preventing further episodes.
Prognosis[edit | edit source]
The prognosis for patients experiencing rearrest depends on several factors, including the time to intervention, the underlying cause, and the patient's overall health status. Early and effective resuscitation efforts can improve outcomes, but the risk of neurological damage or death remains high.
Prevention[edit | edit source]
Preventing rearrest involves comprehensive post-resuscitation care, which includes:
- Continuous Monitoring: Patients should be closely monitored in an intensive care setting.
- Cardiac Support: Use of medications or devices to support cardiac function may be necessary.
- Rehabilitation: Long-term rehabilitation and lifestyle changes can help reduce the risk of future cardiac events.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
